As a leading animal health company, we are committed to bringing the latest technologies to our research efforts. We are focused on advancing veterinary medicine through novel solutions in key therapeutic areas. We have an exceptional track record of discovering and developing first- and best-in-class opportunities in small molecules, vaccine technologies and biotechnologies, such as monoclonal antibodies.

One of our proudest innovations is the SPHEREON technology we developed to freeze-dry live poultry vaccines into small, highly soluble particles (spheres) that make it easier to administer in large batch sizes, among other advances.
We conduct our critical research with multiple research sites focused on both vaccine (biological) and pharmaceutical research. We also maintain research operations focused on local issues and respond quickly to changing market needs.

In today’s competitive, ever-changing business environment, no company can afford to do it alone. We achieve our ambitious goals through internal discovery efforts and co-innovation partnerships with pharmaceutical and crop science companies as well as academic institutions. Furthermore, we invest in adjacent technology opportunities through a dedicated innovation fund.

We also collaborate closely with our colleagues in AgroMedVET to share best practices and leverage the power of our combined research effort.